FindTrial
Sign In

The role of coagulation factor level in the diagnosis and prognosis evaluation of pulmonary embolism in patients with lung cancer

The role of coagulation factor level in the diagnosis and prognosis evaluation of pulmonary embolism in patients with lung cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000035505
Enrollment
Unknown
Registered
2020-08-13
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung cancer, pulmonary embolism

Interventions

Case series:N/A

Sponsors

Xinhua Hospital affiliated to Shanghai Jiaotong University School of Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. All patients are over 18 years old; 2. All patients have a definite histopathological diagnosis of primary pulmonary malignant tumor.

Exclusion criteria

Exclusion criteria: 1. Patients with other malignant tumors other than lung cancer; 2. Patients have a history of chronic pulmonary thromboembolism; 3. Patients have a known thrombotic disorder or clotting disorder; 4. Patients receive treatment affecting coagulation function within 1 week before enrollment; 5. Patients are pregnant or lactating women; 6. Patients refuse to sign the informed consent.

Design outcomes

Primary

MeasureTime frame
Coagulation factors;—

Countries

China

Contacts

Public ContactWei Xiong

Xinhua Hospital affiliated to Shanghai Jiaotong University School of Medicine

xiongwei@xinhuamed.com.cn+86 15601890691

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026